• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

SyntheticMR

0.60 SEK

-3.56 %

Less than 1K followers

SYNT

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-3.56 %
-33.78 %
-35.64 %
-51.92 %
-50.82 %
-79.94 %
-97.36 %
-98.35 %
-71.11 %

SyntheticMR is a medical technology company that is active in the development of analysis and imaging methods. The technology is mainly used for magnetic resonance imaging (MRI) in healthcare. The technology is based on a quantification-based method that aims to increase the efficiency and quality of MRI examinations. The company was founded in 2007 and is headquartered in Linköping.

Read more
Market cap
53.24M SEK
Turnover
43.35K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
25.8.
2026

Interim report Q2'26

25.11.
2026

Interim report Q3'26

16.2.
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release5/27/2026, 5:19 PM

Report from Annual General Meeting in SyntheticMR AB (publ)

SyntheticMR
Regulatory press release5/12/2026, 6:12 AM

Interim report January - March 2026

SyntheticMR
Regulatory press release4/21/2026, 6:02 AM

Notice to attend the Annual General Meeting of SyntheticMR AB (publ)

SyntheticMR

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release4/9/2026, 6:01 AM

SyntheticMR AB: SyntheticMR publishes Annual Report for 2025

SyntheticMR
Regulatory press release4/7/2026, 1:46 PM

Change of date for the Annual General Meeting in SyntheticMR AB (publ)

SyntheticMR
Regulatory press release2/11/2026, 3:51 PM

SyntheticMR AB: SyntheticMR's rights issue has been registered - conversion of BTA into shares

SyntheticMR
Regulatory press release2/6/2026, 7:30 AM

SyntheticMR AB: Year-End report January - December 2025

SyntheticMR
Regulatory press release2/4/2026, 2:16 PM

SyntheticMR AB: SyntheticMR publishes the outcome of the rights issue

SyntheticMR
Press release1/20/2026, 6:19 AM

Today the subscription period commences in SyntheticMR AB's rights issue

SyntheticMR
Regulatory press release1/19/2026, 12:51 PM

SyntheticMR AB publishes information document regarding the rights issue

SyntheticMR
Regulatory press release1/19/2026, 7:48 AM

SyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue

SyntheticMR
Press release1/16/2026, 8:15 AM

SyntheticMR AB: Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR's Position with a Broader Neuroimaging Offering

SyntheticMR
Press release1/15/2026, 7:46 AM

SyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue

SyntheticMR
Regulatory press release1/9/2026, 11:08 AM

Report from the extraordinary general meeting in SyntheticMR AB (publ)

SyntheticMR
Regulatory press release12/18/2025, 8:01 AM

Notice of extra general meeting in SyntheticMR AB (publ)

SyntheticMR
Regulatory press release12/17/2025, 10:03 PM

SyntheticMR AB resolves on a fully secured rights issue of approximately SEK 32.8 million

SyntheticMR
Regulatory press release11/28/2025, 7:00 AM

SyntheticMR AB: Interim report July - September 2025

SyntheticMR
Regulatory press release11/25/2025, 6:07 PM

SyntheticMR AB (publ) postpones the interim report for the third quarter of 2025

SyntheticMR
Regulatory press release11/22/2025, 2:53 PM

Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ)

SyntheticMR
Press release10/29/2025, 7:50 AM

SyntheticMR AB: Nomination Committee appointed for the 2026 Annual General Meeting in SyntheticMR

SyntheticMR